Lars Dyrskjøt Andersen,Torben Falck Orntoft,Joseph A. Sorge,Alexey Novoradovsky
申请号：
US13791370
公开号：
US20130183345A1
申请日:
2013.03.08
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Disclosed is determining expression levels of protective or harmful markers for bladder cancer prognosis and treatment particularly, determining the expression levels of protective markers (COL4A3BP, MBNL2, FABP4, NEK1 and SKAP2) and harmful markers (COL4A1, UBE2C, BIRC5, COL18A1, KPNA2, MSN, ACTA2, and CDC25B) and making treatment decisions in consideration of increased or decreased risk of progression based on the marker expression levels.
